Patents by Inventor Theodore Curtis JESSOP

Theodore Curtis JESSOP has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling
    Patent number: 11634423
    Abstract: The present invention provides a compound of Formula I: wherein R is or a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: April 25, 2023
    Assignee: Eli Lilly and Company
    Inventors: Thomas John Bleisch, Zhaogen Chen, Theodore Curtis Jessop
  • 7 (METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES
    Publication number: 20220024933
    Abstract: The present invention provides a compound of Formula (I) wherein R is (II) or (III); or a pharmaceutically acceptable salt thereof, useful for treating psoriasis or systemic lupus erythematosus.
    Type: Application
    Filed: December 4, 2019
    Publication date: January 27, 2022
    Inventors: Zhaogen CHEN, Theodore Curtis JESSOP
  • 7-(METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE COMPOUNDS
    Publication number: 20210253581
    Abstract: The present invention provides a compound of Formula I: wherein R is or a pharmaceutically acceptable salt thereof, useful for treating psoriasis, systemic lupus erythematosus, or type 1 diabetes.
    Type: Application
    Filed: February 5, 2021
    Publication date: August 19, 2021
    Inventors: Thomas John BLEISCH, Zhaogen CHEN, Theodore Curtis JESSOP